University of Michigan "Nephrology Research BioBank"

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Aug 2026 to Aug 2030v17
  2. Site contact updatedv16
  3. Re-verified, no change to tracked fieldsv15
  4. Collaborators expanded, about 8 wordsv14
  5. 4 versions Re-verified since Oct 23, 2018, no change to tracked fieldsv10-v13
Show 8 earlier versionsHide 8 earlier versions
  1. Primary and study completion dates: Aug 2056 to Aug 2026
    • Eligibility criteria revised
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Interventions: Kidney and/or Pancreas biopsy (Procedure) to not stated
    • Eligibility criteria expanded, about 11 words
    • Study title expanded, about 3 words
    v7
  4. Primary completion date: Aug 2056v6
  5. Re-verified, no change to tracked fieldsv5
  6. Study arms: 0 to 1v4
  7. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  8. Study description shortened, about 9 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Trial Details
NCT Number NCT00381121
Lead Sponsor University of Michigan
Collaborators: amfAR, The Foundation for AIDS Research, Regeneron Pharmaceuticals
Conditions
(from sponsor)		 Chronic Kidney Disease
Related terms Renal Insufficiency, Chronic
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov